STAT1 and glioblastoma: Furthermore, the authors found that treatment of two IFNγ-stimulated patient-derived GBM cell lines with TMZ led to decreased JAK/STAT pathway genes including STAT1 and STAT3, although this was not seen in the commercial LN229 GBM cell line.